JP Morgan Chase
STJ

JP Morgan Chase’s St Jude Medical STJ Stock Holding History

JP Morgan Chase’s Portfolio STJ Stock Details STJ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-250,900
Closed -$15.5M – 5162
2015
Q4 		$15.5M Buy
+250,900
New +$15.8M ﹤0.01% 1517
2015
Q3 		– Sell
-223,500
Closed -$16.3M – 4233
2015
Q2 		$16.3M Buy
+223,500
New +$16.1M ﹤0.01% 1540
2015
Q1 		– Sell
-50,000
Closed -$3.25M – 4407
2014
Q4 		$3.25M Buy
+50,000
New +$3.22M ﹤0.01% 2675

Other funds holding STJ

FPF
FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return
JWA
JFS Wealth Advisors Hermitage, Pennsylvania $2.01B AUM 21.74% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
AIM
Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

JP Morgan Chase's STJ Position: Q1 2017 in Review

JP Morgan Chase sold out of St Jude Medical (STJ) in Q1 2017, closing a stake of 1,982,745 shares — an estimated $159M sold.

JP Morgan Chase first reported a position in STJ in Q2 2013 and held it in 15 quarters. The position peaked at $159M in Q4 2016. 4 funds tracked by Wall St. Rank hold STJ as of Q1 2017.

  • JP Morgan Chase reported no remaining St Jude Medical position as of Q1 2017 after selling out during the quarter.
  • JP Morgan Chase sold 1,982,745 St Jude Medical shares in Q1 2017, an estimated $159M.
  • JP Morgan Chase first reported a position in St Jude Medical in Q2 2013 and held it in 15 quarters.
  • JP Morgan Chase's St Jude Medical position peaked at $159M in Q4 2016.
  • 4 funds tracked by Wall St. Rank held St Jude Medical as of Q1 2017.

Based on JP Morgan Chase's 13F filing for Q1 2017, filed 10 May 2017.